RAMSAY HEALTH CARE LIMITED (RHC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RHC - RAMSAY HEALTH CARE LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Founded in Sydney in 1964, Ramsay Health Care is the largest provider of private healthcare in Australia, with operations in the UK, France, Indonesia and Malaysia. The company specialises in surgery, rehabilitation and psychiatric care. It was first listed in 1997.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$64.22

29 Jul
2021

0.530

OPEN

$63.68

0.83%

HIGH

$64.28

0

LOW

$63.66

TARGET
$68.184 6.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . SHL . VRT . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
RHC: 1
Title FY19
Actual
FY20
Actual
FY21
Forecast
FY22
Forecast
EPS (cps) xxx 131.0 199.0 xxx
DPS (cps) xxx 62.5 124.3 xxx
EPS Growth xxx - 50.5% 51.9% xxx
DPS Growth xxx - 58.7% 98.8% xxx
PE Ratio xxx N/A 32.2 xxx
Dividend Yield xxx N/A 1.9% xxx
Div Pay Ratio(%) xxx 47.7% 62.4% xxx

Dividend yield today if purchased 3 years ago: 1.11%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.97

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 08/03 - 48.5c (100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201520162017201820192020
EPS Basic xxxxxxxxxxxxxxx131.0
DPS All xxxxxxxxxxxxxxx62.5
Sales/Revenue xxxxxxxxxxxxxxx11,972.8 M
Book Value Per Share xxxxxxxxxxxxxxx1,537.2
Net Operating Cash Flow xxxxxxxxxxxxxxx1,728.0 M
Net Profit Margin xxxxxxxxxxxxxxx2.37 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxxxxxx xx xxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

21/07/2021

1

Buy

$69.00

7.44%

Previous increases to FY22-24 EPS forecasts are now reversed-out by Citi, after Ramsay Health Care announced the proposed Spire Healthcare acquisition will not proceed. The company was unable to secure the required 75% approval from Spire’s shareholders.

While the acquisition would have made strategic and financial sense, given the operational synergies, the analyst expects the company will continue to invest in its core Australian hospital business. This segment generates the highest return on capital.

Citi reduces its target to $69 from $76 and retains its Buy rating.

FORECAST
Citi forecasts a full year FY21 dividend of 148.50 cents and EPS of 210.90 cents.
Citi forecasts a full year FY22 dividend of 201.00 cents and EPS of 284.80 cents.

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

RHC STOCK CHART